Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068545 · ClinicalTrials.gov registry record
Experiences With New Digital Surgical Drainage System in Thoracic Surgery
A clinical trial of Pulmonary Air Leak, sponsored by Centese.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04068545: Completed study of Pulmonary Air Leak, sponsored by Centese.
NCT04068545 is a study of Pulmonary Air Leak that has completed, run by Centese. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068545, a study of Pulmonary Air Leak, has completed, sponsored by Centese.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids and air following thoracic surgery. Observations, experiences, and outcomes in a single hospital setting will be collected for the Thoraguard Surgical Drainage System.
Primary Outcome
The Device User Experience Survey is an unvalidated, Sponsor-generated questionnaire aimed to increase the Sponsor's understanding of the usability of the Thoraguard Surgical Drainage System. The questionnaire asks approximately 15 questions (includes yes/no responses, rating scales, and fill-in-the-blank sections) and is to be completed by the treating clinicians at the completion of the study. A summary of all treating clinician responses will be generated at the completion of the study to sum
Conditions Studied
Interventions
- DEVICE Device: Thoraguard Surgical Drainage System
Study Locations (1)
New York
- NYU School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-09-02 |
| Est. Completion | 2020-05-30 |
What the finished NCT04068545 record still lists
NCT04068545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Pulmonary Air Leak appearing as the primary indexed condition, and to 1 intervention - of which Device: Thoraguard Surgical Drainage System is the first listed.
NCT04068545 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04068545 about?
NCT04068545 is a clinical study titled "Experiences With New Digital Surgical Drainage System in Thoracic Surgery". The purpose of this study is to evaluate the Thoraguard Surgical Drainage System in a real-world clinical environment. It is believed that this system will offer functional and clinical benefits over the current standard of care system for the removal of surgical fluids and air following thoracic su...
What is the current status of trial NCT04068545?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-09-02. Estimated completion is 2020-05-30.
What conditions does trial NCT04068545 study?
This clinical trial studies the following conditions: Pulmonary Air Leak.
What interventions are being tested in trial NCT04068545?
The interventions under investigation include: Device: Thoraguard Surgical Drainage System (DEVICE).
Who is sponsoring clinical trial NCT04068545?
This trial is sponsored by Centese, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04068545 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI